Clinical Trials Directory

Trials / Completed

CompletedNCT02624843

Bioequivalence Study for Benzyl Alcohol Lotion 5%.

Bioequivalence Study for Benzyl Alcohol Lotion 5% (Hi-Tech Pharmacal Co. LTD) and Ulesfia (Benzyl Alcohol Lotion 5%) (Shionogi Inc.) in the Treatment of Head Lice and Their Ova.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
239 (actual)
Sponsor
Akorn, Inc. · Industry
Sex
All
Age
6 Months – 60 Years
Healthy volunteers
Accepted

Summary

To establish the therapeutic equivalence and safety of a generic Benzyl Alcohol Lotion 5% with Ulesfia Lotion 5% in eradication of head lice in the study subjects.

Conditions

Interventions

TypeNameDescription
DRUGBenzyl Alcohol Lotion 5%White topical lotion
DRUGUlesfia (benzyl alcohol lotion) 5%White topical lotion
DRUGPlaceboWhite topical lotion

Timeline

Start date
2015-08-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2015-12-09
Last updated
2021-01-27
Results posted
2020-09-03

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02624843. Inclusion in this directory is not an endorsement.